SENZUMODERN REBIRTHMy account Liraglutide
Also known as Saxenda · Victoza
The SCALE randomized trial found greater weight reduction with liraglutide plus lifestyle intervention than with placebo plus lifestyle intervention. Product labels differ by indication and eligible population.
- Evidence maturity
- Established record
- Regulatory status
- FDA approved
- Recorded outcomes
- 3
- Indexed sources
- 2
This profile does not recommend a compound, dose, supplier, or treatment plan. Discuss personal decisions with a qualified clinician who knows your history.
Summary
A daily GLP-1 receptor agonist with FDA-approved products for weight management and diabetes-related indications.
What is Liraglutide being studied for?
Weight management and type 2 diabetes
How is it thought to work?
Activates the GLP-1 receptor to affect glucose-dependent insulin secretion, glucagon, appetite, and gastric emptying.
Recorded outcomes
3 graded outcomes and 2 sources for Liraglutide.
The graded outcome table, how each grade was decided, the regulatory detail, and every source with its link and identifier open with a free account. No payment details required.
Update history
- Editorial review of the profile and its sources.
- Record last updated in the Senzu database.
- Profile first published.